Complex Chronic Diseases Program Data Registry

Sponsor

BC Women's Hospital & Health Centre (Other)

Overall Status

Enrolling by invitation

CT.gov ID

NCT03409653

Collaborator

Ministry of Health, Province of British Columbia (Other)

1,300

Enrollment

Location

51.6

Anticipated Duration (Months)

25.2

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The purpose of this data registry is to prospectively collect data from patients referred to an Complex Chronic Diseases Program (CCDP) at BC Women's Hospital + Health Centre to assess the quality of life of the CCDP Patients before, during and after their care at the CCDP.

Condition or Disease	Intervention/Treatment	Phase
Fibromyalgia Chronic Fatigue Syndrome Myalgic Encephalomyelitis Chronic Lyme-Like Syndrome

Detailed Description

Before their initial intake appointment, all CCDP patients are given a patient binder that includes the baseline Standardized Questionnaires. These are clinical questionnaires that all patients complete regardless of whether or not they consent to participation in research. In addition to the questionnaires completed at baseline, patients who consent to participate in the data registry will complete the questionnaires, via email or paper copy, at the following time points: approximately 6 months after intake, at discharge and 3 months post-discharge.
Patients who consent to the data registry will also be asked to complete a short questionnaire collecting basic demographic information at baseline. The demographic questionnaire will be either mailed to their home or sent via an online link; the investigators will ask participants to complete this form either before or when they come in for their first in-person visit at the CCDP.
Additional data will be collected and entered from the clinical chart. Specifically, after the patient's initial clinic appointment, the Research Coordinator or designate will enter data points from the Interdisciplinary Assessment Tool, into REDCap.

Study Design

Study Type:

Observational [Patient Registry]

Anticipated Enrollment :

1300 participants

Observational Model:

Cohort

Time Perspective:

Prospective

Official Title:

Complex Chronic Diseases Program Data Registry

Actual Study Start Date :

Jun 12, 2017

Anticipated Primary Completion Date :

Sep 30, 2021

Anticipated Study Completion Date :

Sep 30, 2021

Outcome Measures

Primary Outcome Measures

Change in quality of life [Baseline (pre-intake), 6 months, discharge (an average of 21 months), 3 months post-discharge]
Change in self-reported quality of life assessed by structured questionnaire (36 Item Short Form Health Survey (SF-36))

Secondary Outcome Measures

Brief Pain Inventory Short Form (BPI-SF) [Baseline (pre-intake), 6 months, discharge (an average of 21 months), 3 months post-discharge]
The BPI-SF is a self-reported standard questionnaire used to evaluate the severity of pain and the impact of this pain on the patient's daily functioning.
Fatigue Severity Scale (FSS) [Baseline (pre-intake), 6 months, discharge (an average of 21 months), 3 months post-discharge]
The FSS is a self-reported standard questionnaire that uses a scale to measures the severity of the fatigue and its effect on a person's activities and lifestyles in patients with a variety of disorders. It uses a 7- point Liker scale, where 1=Strongly Disagree and 7= Strongly agree. Score range is 1-7. Higher schore indicates more severe fatigue.
McGill Pain Questionnaire Short Form [Baseline (pre-intake), 6 months, discharge (an average of 21 months), 3 months post-discharge]
The McGill Pain Questionnaire Short Form is self-reported standard questionnaire. It is used to describes the subjective overall intensity of the total pain experience.
Pittsburgh Sleep Quality Index (PSQI) [Baseline (pre-intake), 6 months, discharge (an average of 21 months), 3 months post-discharge]
The PSQI is a self-reported standard questionnaires. It is used to assess sleep quality and disturbances.
Patient Health Questionnaire 9 (PHQ - 9) [Baseline (pre-intake), 6 months, discharge (an average of 21 months), 3 months post-discharge]
The PHQ-9 is a self-reported standard questionnaire used to screen, diagnose, monitor and measure the severity of depression.
Generalized Anxiety Disorder - 7 item (GAD - 7) [Baseline (pre-intake), 6 months, discharge (an average of 21 months), 3 months post-discharge]
The GAD-7 is a self-reported standard questionnaire used to measures the severity of various signs of general anxiety disorder according to response categories with assigned points.

Eligibility Criteria

Criteria

Ages Eligible for Study:

18 Years and Older

Sexes Eligible for Study:

All

Accepts Healthy Volunteers:

Inclusion Criteria:

Newly referred patients of the Complex Chronic Diseases Program
Must be able to read and understand English
18 years of age or older

Exclusion Criteria:

Have not completed the Standardized Questionnaires booklet prior to the initial intake assessment.

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	BC Women's Hospital + Health Centre	Vancouver	British Columbia	Canada	V6H 3N1

Sponsors and Collaborators

BC Women's Hospital & Health Centre
Ministry of Health, Province of British Columbia

Investigators

Principal Investigator: Luis C Nacul, MD, Medical Director CCDP, Complex Chronic Care Clinic
Study Chair: Wee-Shian Chan, MD, Department Head, Medicine